Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Products are available through a customizable catalog on Opal, including Bausch + Lomb contact lens brands such as Bausch + Lomb INFUSE®, Bausch + Lomb ULTRA® and Biotrue® ONEday. Over-the ...

lenses for the first satellite pictures of the moon . . . products for eye surgery . . . and the first soft contact lenses. The relationship between Bausch & Lomb and the Rochester Institute of ...

The company operates through five main business segments — Bausch + Lomb, Salix Pharmaceuticals, International Rx, Solta ...

over-the-counter products and ophthalmic surgical devices and instruments. Read More on BLCO: Bausch + Lomb Corporation Registered Shs Reg S NewsMORE Related Stocks Indices Commodities ...

over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint ...

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products.